The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		1 Months Ended
	May 11, 2020	Feb. 27, 2020	Feb. 17, 2020
Entity own interest			18.18%
Amount paid for research and development expenses			$ 35,848
Working capital loan	$ 600,000
Current exchange rate			$ 6.7473
Patent Transfer Agreement [Member]
Exchange rate		$ 6.4500
Consideration paid for two patents		$ 21,705
Entrustment Technical Service Agreement [Member]
Exchange rate		$ 6.4500
Amount payable for harvesting		$ 30,408
Beijing Zhenhuikang Biotechnology Co. LTD [Member] \| Patent Transfer Agreement [Member]
Current exchange rate		$ 6.5286
Patents acquistions, consideration paid		$ 21,444
Beijing Zhenhuikang Biotechnology Co. LTD [Member] \| Entrustment Technical Service Agreement [Member]
Current exchange rate		$ 6.4500
Harvesting packages		$ 30,977
Mr. Yulin Cao [Member] \| Beijing Zhenxigu Medical Research Center LP [Member]
Entity own interest			18.18%
Amount paid for research and development expenses			$ 35,848
Current exchange rate			$ 6.7473